Endocrine Abstracts

Objectives: Various systemic symptoms may occur in patients with thyrotoxicosis. Gastrointestinal manifestations such as hyperphagia or frequent defecation, often coexist with other thyrotoxic symptoms. Vomiting also has been mentioned.In this setting, systemic symptoms of underlying malignancy may be confused with those of thyrotoxicosis leading to a delay in diagnosis.Methods: We report a case with delayed diagnosis of small bowe...

Introduction: There are few cases about arterial thrombosis combined with thyrotoxicosis independent of atrial arrhythmias. Herein, we report a case of Graves’ disease presented with renal artery infarction withiout atrial fibrillation.Case: A 54-year-old man visited the emergency department due to the sudden onset of left flank pain for 30 min. The left flank pain was accompanied by sole dysuria without other symptoms of pyelonephritis. Physical ex...

Introduction: The degree of dyslipidemia caused by iatrogenic hypothyroidism is not clear in DTC. Therefore, we investigated the average of lipid profile change caused by LT4 withdrawal in the follow-up of DTC.Method: We enrolled 84 DTC patients who underwent high-dose RAI therapy for the treatment of recurred or remnant DTC and we measured serum levels of total cholesterol, triglyceride, LDL, and HDL and then analyzed changes in them accordin...

Background: Non-alcoholic fatty liver disease (NAFLD) is metabolic disorder of the liver that is associated with type 2 diabetes.The relationship between NAFLD and diabetic neuropathy was still poorly understood. This study aimed to investigate whether the NAFLD is associated with the autonomic neuropathy parameters in patients with type 2 diabetes.Methods: A total of 174 patients with type 2 diabetes were included in this study. Patients were divided in...

Background: Regular monitoring of glucose control and screening of diabetic complication and adherence to treatment are cornerstones for prevention of chronic diabetic complications. The aim of this study is to investigate the association between quality of diabetes care and the development of chronic diabetes complications.Methods: This retrospective study was performed using the national health insurance claims database from the Health Insurance Review...

Objective: Cilostazol, a selective inhibitor of phosphodiesterase 3, which has been widely used in patients with atherosclerotic diseases, is known to have additional beneficial effects on dyslipidemia. ATP-binding cassette transporter A1 (ABCA1) plays a critical role in the regulation of intracellular cholesterol levels in hepatocytes. We aimed to investigate the effect of Cilostazol on hepatic steatosis and its underlying mechanism related to ABCA1.Met...